Internal Med

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

M. Pimentel, et al. - The objective is to determine whether the nonabsorbed antibiotic rifaximin is more effective than placebo in reducing symptoms in adults with IBS...Over the 10 weeks of follow-up, rifaximin resulted in greater improvement in IBS symptoms (P = 0.020). In addition, rifaximin recipients had a lower bloating score after treatment

Related Articles

Irritable bowel syndrome: Role of food in pathogenesis and management
Journal of Digestive Diseases, 10/30/09    Relevance Score: 81%

Rectal Sensory Threshold for Pain is a Diagnostic Marker of Irritable Bowel Syndrome and Functional Abdominal Pain in Children
The Journal of Pediatrics, 10/08/09    Relevance Score: 81%

Celiac disease in patients with presumed irritable bowel syndrome: A case-finding study
World Journal of Gastroenterology, 11/17/09    Relevance Score: 79%

Prebiotics for irritable bowel syndrome
Expert Review of Gastroenterology & Hepatology, 10/16/09    Relevance Score: 79%

5-hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status
Alimentary Pharmacology and Therapeutics, 10/09/09    Relevance Score: 79%

Today in Clinical Pharmacology...keeping you current

Update on the efficacy, effectiveness and safety of artemether–lumefantrine combination therapy for treatment of uncomplicated malaria
Therapeutics and Clinical Risk Management, 12/20/09

How do providers assess antihypertensive medication adherence in medical encounters?
Journal of General Internal Medicine, 12/19/09

Nilotinib As Front-Line Treatment for Patients With Chronic Myeloid Leukemia in Early Chronic Phase
Journal of Clinical Oncology, 12/19/09